Check Cap (NASDAQ:CHEK) Stock Rating Lowered by Zacks Investment Research

Share on StockTwits

Zacks Investment Research downgraded shares of Check Cap (NASDAQ:CHEK) from a hold rating to a sell rating in a report published on Wednesday, Zacks.com reports.

According to Zacks, “Check Cap Ltd. is a medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule for the screening of colorectal cancer. Check Cap Ltd. is based in Mount Carmel, Israel. “

Separately, HC Wainwright restated a buy rating and issued a $15.00 price objective on shares of Check Cap in a research note on Wednesday, July 10th.

Shares of NASDAQ CHEK traded down $0.12 during mid-day trading on Wednesday, reaching $1.75. The company had a trading volume of 18,600 shares, compared to its average volume of 166,310. Check Cap has a 12-month low of $1.55 and a 12-month high of $4.20. The stock has a fifty day moving average of $1.86 and a two-hundred day moving average of $2.12.

Check Cap (NASDAQ:CHEK) last announced its quarterly earnings results on Wednesday, November 6th. The medical research company reported ($0.42) EPS for the quarter, meeting the consensus estimate of ($0.42). On average, analysts predict that Check Cap will post -1.69 EPS for the current year.

A hedge fund recently raised its stake in Check Cap stock. Renaissance Technologies LLC lifted its stake in Check Cap Ltd (NASDAQ:CHEK) by 24.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 307,468 shares of the medical research company’s stock after acquiring an additional 60,026 shares during the period. Renaissance Technologies LLC owned approximately 19.16% of Check Cap worth $652,000 at the end of the most recent reporting period.

About Check Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays for screening of the colon to detect polyps, masses, and colorectal cancers in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a biocompatible unit worn on the patient's back for capsule control, tracking, and data recording; and C-Scan View, a personal computer-based software package, which is designed to retrieve and process clinical data from the C-Scan Track, and to reconstruct and produce 3D visualization of the colon's inner surface.

Further Reading: What is a resistance level?

Get a free copy of the Zacks research report on Check Cap (CHEK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Check Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check Cap and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.